Author

Tamika Malone

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 3 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1

Frequent Co-Authors

David WeinshenkeriD· 4 shared Gary Jonathan BasselliD· 4 shared Jennifer Gladys MulleiD· 4 shared Rebecca M. PollakiD· 4 shared Ryan H. PurcelliD· 4 shared Stephen T. WarreniD· 4 shared Tamara CasparyiD· 4 shared Michael P. EpsteiniD· 3 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetics

David WeinshenkerORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Convergent and distributed effects of the schizophrenia-associated 3q29 deletion on the human neural transcriptome

Esra Sefik, Ryan H. Purcell, The Emory 3q29 Project, Katrina Aberizk, Hallie Averbach, Emily Black, Teresa Lindsey Burrell, Shanthi Cambala, Grace Carlock, Tamara Caspary, Joseph F. Cubells, David J. Cutler, Paul A. Dawson, Michael T. Epstein, Roberto España, , Jennifer Gladys Mulle

This study investigates the molecular effects of the 3q29 deletion on the human neural transcriptome, identifying convergent and distributed impacts across gene clusters and pathways related to psychiatric disorders.

Translational Psychiatry · Jun 15, 2021Peer-reviewedGenetics

Comprehensive phenotyping of 3q29 deletion syndrome: recommendations for clinical care

Rossana Sanchez Russo, Michael J. Gambello, Melissa M. Murphy, Katrina Aberizk, Emily Black, Teresa Lindsey Burrell, Grace Carlock, Joseph F. Cubells, Michael T. Epstein, Roberto España, Katrina Goines, Ryan M. Guest, Cheryl Klaiman, Sookyong Koh, Elizabeth J. Leslie, , Jennifer Gladys Mulle

This study evaluates 32 individuals with 3q29 deletion syndrome to identify common medical and neurodevelopmental features and provides clinical care recommendations.

Genetics in Medicine · Feb 9, 2021Peer-reviewedGenetic & Genomic Medicine

Metabolic effects of the schizophrenia-associated 3q29 deletion are sex-specific and uncoupled from behavioral phenotypes

Rebecca M. Pollak, Ryan H. Purcell, Timothy P. Rutkowski, Tamika Malone, Kimberly J. Pachura, Gary Jonathan Bassell, Michael P. Epstein, Paul A. Dawson, Matthew Ryan Smith, Dean P. Jones, Michael E. Zwick, the Emory 3q29 Project, Stephen T. Warren, Tamara Caspary, David Weinshenker, Jennifer Gladys Mulle

This study shows that the 3q29 deletion causes sex-specific metabolic changes in mice, which are not linked to behavioral issues, and that a high-fat diet can improve weight in females without worsening behavior.

bioRxiv · Sep 18, 2020 · PreprintGenetics

Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion

Timothy P. Rutkowski, Ryan H. Purcell, Rebecca M. Pollak, Stephanie M. Grewenow, Georgette M. Gafford, Tamika Malone, Uswa A. Khan, Jason P. Schroeder, Michael P. Epstein, Gary Jonathan Bassell, Stephen T. Warren, David Weinshenker, Tamara Caspary, Jennifer Gladys Mulle

This study creates a CRISPR-engineered mouse model of the 3q29 deletion, showing behavioral and growth deficits, and demonstrates that these effects are not solely due to Dlg1 haploinsufficiency.

Molecular Psychiatry · Apr 11, 2019Peer-reviewedGenetics